Postpartum thyroiditis screening: Difference between revisions
Sunny Kumar (talk | contribs) No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{SKA}} | {{CMG}}; {{AE}} {{SKA}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for [[Postpartum thyroiditis|postpartum thyroiditis"PPT"]]. According to the American Journal of Obstetrics and Gynecology screening for [[postpartum thyroiditis]] by measuring anti-TPO [[antibodies]] is recommended every pregnant women. According to the Endocrinology and Metabolism Clinics of North America screening for [[postpartum thyroiditis]] in first trimester by measuring anti-TPO [[antibodies]] should be limited to every high-risk pregnant women with [[Diabetes mellitus type 1|type 1 DM]], history of [[postpartum thyroiditis]] and any patient with high risk should be followed with [[Thyroid-stimulating hormone|TSH]] levels every 6th and 9th postpartum period. | There is insufficient evidence to recommend routine screening for [[Postpartum thyroiditis|postpartum thyroiditis"PPT"]]. According to the American Journal of Obstetrics and Gynecology screening for [[postpartum thyroiditis]] by measuring anti-[[Thyroid peroxidase|TPO]] [[antibodies]] is recommended every pregnant women. According to the Endocrinology and Metabolism Clinics of North America screening for [[postpartum thyroiditis]] in first trimester by measuring anti-[[Thyroid peroxidase|TPO]] [[antibodies]] should be limited to every high-risk pregnant women with [[Diabetes mellitus type 1|type 1 DM]], history of [[postpartum thyroiditis]] and any patient with high risk should be followed with [[Thyroid-stimulating hormone|TSH]] levels every 6th and 9th postpartum period. | ||
==Screening== | ==Screening== | ||
Revision as of 13:59, 18 October 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis screening On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis screening |
|
Risk calculators and risk factors for Postpartum thyroiditis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
There is insufficient evidence to recommend routine screening for postpartum thyroiditis"PPT". According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women. According to the Endocrinology and Metabolism Clinics of North America screening for postpartum thyroiditis in first trimester by measuring anti-TPO antibodies should be limited to every high-risk pregnant women with type 1 DM, history of postpartum thyroiditis and any patient with high risk should be followed with TSH levels every 6th and 9th postpartum period.
Screening
- There is insufficient evidence to recommend routine screening for PPT.
- According to the American Journal of Obstetrics and Gynecology screening for postpartum thyroiditis by measuring anti-TPO antibodies is recommended every pregnant women.[1]
- According to the Endocrinology and Metabolism Clinics of North America screening for postpartum thyroiditis in first trimester by measuring anti-TPO antibodies should be limited to every high risk pregnant women with: [2]
- Type 1 DM.
- History of postpartum thyroiditis.
- Any patient with high risk should be followed with TSH levels every 6th and 9th postpartum period.[3]
References
- ↑ Hayslip CC, Fein HG, O'Donnell VM, Friedman DS, Klein TA, Smallridge RC (1988). "The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction". Am J Obstet Gynecol. 159 (1): 203–9. PMID 3394739.
- ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.
- ↑ Keely EJ (2011). "Postpartum thyroiditis: an autoimmune thyroid disorder which predicts future thyroid health". Obstet Med. 4 (1): 7–11. doi:10.1258/om.2010.100041. PMC 4989649. PMID 27579088.